Seoul, South Korea

Min-Jeong Shin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Min-Jeong SHIN:

Title: Innovator Spotlight: Min-Jeong SHIN Shaping the Future of Anticancer and Obesity Treatment

Introduction:

Min-Jeong SHIN is a visionary inventor based in Seoul, South Korea, dedicated to revolutionizing the field of pharmaceuticals. With a passion for developing groundbreaking solutions, Min-Jeong SHIN has already made a mark with his innovative patents in the realms of anticancer and obesity treatment.

Latest Patents:

1. Anticancer pharmaceutical composition containing IF1 as an active ingredient: In this patent, Min-Jeong SHIN introduces an anticancer composition containing IF1 (ATPase inhibitory factor 1). This invention showcases the potential of IF1 in inducing cytotoxicity in various cancer cells, releasing extracellular ATP, and exhibiting strong anticancer efficacy. It stands as a promising active ingredient for potent anticancer agents.

2. Appetite suppression with pharmaceutical compositions containing biglycan as an active ingredient: Min-Jeong SHIN's second patent focuses on a pharmaceutical composition designed to suppress appetite and combat obesity. By leveraging biglycan as the active ingredient, this invention targets the expression of key appetite-regulating peptides, paving the way for effective obesity treatment solutions.

Career Highlights:

Min-Jeong SHIN has contributed his expertise to renowned institutions such as the Korea University Research and Business Foundation and the Daegu Gyeongbuk Institute of Science and Technology. His career is punctuated with a relentless pursuit of innovation and a commitment to creating impactful pharmaceutical solutions for pressing health challenges.

Collaborations:

Throughout his journey, Min-Jeong SHIN has collaborated with esteemed professionals in the field, including Hyeon Soo Kim and Eun-Kyoung KIM. These partnerships have enriched his projects and catalyzed the development of cutting-edge pharmaceutical solutions.

Conclusion:

Min-Jeong SHIN's inventive spirit and dedication to advancing pharmaceutical innovation are evident in his groundbreaking patents and collaborative ventures. His work stands as a testament to the transformative power of innovation in shaping the future of healthcare. As he continues to push boundaries and explore new frontiers, Min-Jeong SHIN emerges as a trailblazing figure in the realm of pharmaceutical inventions, poised to make a lasting impact on global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…